PSP Gene - Persephin

PSP Gene - Persephin

Introduction

Psp Gene Persephin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@baloh1998]
<table> [@airaksinen2002]
<tr><th colspan="2" style="background:#f0f0f0;">PSP</th></tr> [@masure1999]
<tr><td><b>Full Name</b></td><td>Persephin</td></tr>
<tr><td><b>Category</b></td><td>Gene</td></tr>
<tr><td><b>Path</b></td><td>/genes/psp</td></tr>
<tr><td><b>Chromosome</b></td><td>19q13.33</td></tr>
<tr><td><b>Protein</b></td><td>Persephin</td></tr>
<tr><td><b>Family</b></td><td>GDNF family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">126 edges</a></td>
</tr>
</table>
</div>

Overview

PSP Gene - Persephin

Introduction

Psp Gene Persephin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@baloh1998]
<table> [@airaksinen2002]
<tr><th colspan="2" style="background:#f0f0f0;">PSP</th></tr> [@masure1999]
<tr><td><b>Full Name</b></td><td>Persephin</td></tr>
<tr><td><b>Category</b></td><td>Gene</td></tr>
<tr><td><b>Path</b></td><td>/genes/psp</td></tr>
<tr><td><b>Chromosome</b></td><td>19q13.33</td></tr>
<tr><td><b>Protein</b></td><td>Persephin</td></tr>
<tr><td><b>Family</b></td><td>GDNF family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">126 edges</a></td>
</tr>
</table>
</div>

Overview

PSP (Persephin) is a member of the glial cell line-derived neurotrophic factor (GDNF) family. It was discovered in 1999 and encodes a secreted neurotrophic factor. While less studied than GDNF, Neurturin, and Artemin, persephin has shown promising neuroprotective properties, particularly for motor [neurons](/entities/neurons) and dopaminergic neurons.

Function

Persephin mediates its effects through specific receptor interactions:

Receptor Signaling

• Primary receptor: GFRα4 (GDNF Receptor Alpha 4)
• Co-receptor: RET (Rearranged during transfection)
• Binding triggers downstream signaling including:
• PI3K/Akt pathway
• MAPK/ERK pathway
• PLCγ pathway

Neuroprotective Effects

Persephin has demonstrated neurotrophic activity:

• Motor Neuron Survival: Supports survival and differentiation of motor neurons
• Dopaminergic Neuroprotection: Protects dopaminergic neurons in models of Parkinson's disease
• Renal Development: Essential for ureteric bud development and kidney morphogenesis
• Enteric Neurons: Supports survival of enteric nervous system neurons

Comparative Pharmacology

Interestingly, persephin has unique properties compared to other GDNF family members:

• GFRα4 has high specificity for persephin
• Some studies suggest weaker trophic effects compared to GDNF for dopaminergic neurons
• May have different therapeutic potential due to distinct receptor binding profiles

Disease Associations

Parkinson's Disease

Persephin has been investigated as a potential therapeutic:

• Protects dopaminergic neurons in 6-OHDA and MPTP models
• Less likely to cause side effects compared to GDNF (due to more restricted receptor distribution)
• Preclinical studies show promise for neuroprotection

Motor Neuron Diseases

• Amyotrophic Lateral sclerosis (ALS): Persephin has shown protective effects on motor neurons
• Spinal Muscular Atrophy (SMA): May support motor neuron survival

Renal Disorders

• Congenital kidney malformations in PSP-deficient mice
• Potential therapeutic for renal hypoplasia

Expression

PSP shows tissue-specific expression:

• Brain:
• Moderate expression in striatum and substantia nigra
• Lower expression in [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
• Kidney: High expression during development
• Testis: Expression in developing and adult testis
• Peripheral tissues: Lower expression in heart, lung, skeletal muscle

Therapeutic Potential

Persephin represents a promising therapeutic candidate:

Advantages over GDNF

• More restricted receptor distribution may reduce side effects
• May not cause weight loss or keloid formation seen with GDNF
• Potential for more targeted delivery

Challenges

• Limited preclinical data compared to other GDNF family members
• Delivery to the CNS remains challenging
• Requires further clinical validation

Key Publications

See Also

• [Neurotrophic Factors](/mechanisms/neurotrophic-factors)
• [PSP Protein](/proteins/psp-protein)
• [GDNF Family in Neurodegeneration](/mechanisms/gdnf-family-neurodegeneration)
• [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
• [Motor Neuron Disease](/diseases/amyotrophic-lateral-sclerosis)
• [Genes Index](/genes)

External Links

• [Wikipedia](https://en.wikipedia.org/wiki/Persephin)
• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/5673)
• [UniProt](https://www.uniprot.org/O76093)
• [GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSP)

Background

The study of Psp Gene Persephin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

CBS/PSP Cross-Link Navigation

Core Disease Pages

• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
• [Corticobasal Degeneration](/diseases/corticobasal-degeneration)
• [Primary Age-Related Tauopathy](/diseases/primary-age-related-tauopathy)
• [Aging-Related Tauopathy](/diseases/aging-related-tauopathy)
• [PSP Genetic Variants](/diseases/psp-genetic-variants)

Mechanisms

• [4R Tauopathy Molecular Mechanisms](/mechanisms/4r-tauopathy-mechanisms)
• [Tauopathy](/mechanisms/tauopathy)
• [Cortisol-Tau Pathway](/mechanisms/cortisol-tau-pathway)
• [Gut-Brain Axis in Tauopathy](/mechanisms/gut-brain-axis-tauopathy)
• [CBS/PSP Genetic Architecture](/mechanisms/cbs-psp-genetic-architecture)
• [PSP Pathway](/mechanisms/psp-pathway)
• [CBD Pathway](/mechanisms/cbd-pathway)

Biomarkers

• [Tau PET in CBS/PSP](/biomarkers/tau-pet-cbs-psp)
• [MRI Atrophy Patterns in CBS/PSP](/biomarkers/mri-atrophy-cbs-psp)
• [DTI White Matter Changes in CBS/PSP](/biomarkers/dti-white-matter-cbs-psp)
• [CSF Biomarkers for CBS/PSP](/biomarkers/cbs-psp-csf-biomarkers)
• [Plasma Biomarkers for CBS/PSP](/biomarkers/cbs-psp-plasma-biomarkers)
• [Imaging Biomarkers for CBS/PSP](/biomarkers/cbs-psp-imaging-biomarkers)
• [PSP Biomarkers](/biomarkers/progressive-supranuclear-psp-biomarkers)

Cell-Type Nodes

• [Tauopathy Neurons in PSP](/cell-types/progressive-supranuclear-palsy-tau-neurons)
• [Progressive Supranuclear Palsy Neurons](/cell-types/progressive-supranuclear-palsy-neurons)
• [Substantia Nigra Neurons in PSP](/cell-types/substantia-nigra-neurons-progressive-supranuclear-palsy)
• [Substantia Nigra Dopamine in CBD](/cell-types/substantia-nigra-cbd)
• [Locus Coeruleus Noradrenergic in PSP](/cell-types/locus-coeruleus-psp)
• [Nigral Microglia in PSP](/cell-types/nigral-microglia-psp)
• [Globus Pallidus Neurons in PSP](/cell-types/globus-pallidus-neurons-progressive-supranuclear-palsy)
• [Subthalamic Nucleus Neurons in PSP](/cell-types/subthalamic-nucleus-psp)

Therapeutic & Care Guides

• [CBS/PSP Daily Action Plan](/therapeutics/cbs-psp-daily-action-plan)
• [CBS/PSP Rehabilitation Guide](/therapeutics/cbs-psp-rehabilitation-guide)
• [CBS/PSP Clinical Trials Guide](/therapeutics/cbs-psp-clinical-trials-guide)
• [CBS/PSP Treatment Rankings](/therapeutics/cbs-psp-treatment-rankings)
• [Protective Strategies for CBS/PSP](/therapeutics/protective-strategies-cbs-psp)
• [Exercise for CBS/PSP](/therapeutics/exercise-cbs-psp)
• [Rapamycin for Tauopathy](/therapeutics/rapamycin-tauopathy)
• [Lithium for Tauopathy](/therapeutics/lithium-tauopathy)
• [Mitochondrial Support Strategies for CBS/PSP](/therapeutics/mitochondrial-neuroprotection)

Related NeuroWiki Pages

Core CBS/PSP Disorders

• [Progressive Supranuclear Palsy (PSP)](/diseases/progressive-supranuclear-palsy)
• [Corticobasal Degeneration (CBD)](/diseases/corticobasal-degeneration)
• [Corticobasal Syndrome (CBS)](/diseases/corticobasal-syndrome)
• [Primary Age-Related Tauopathy (PART)](/diseases/primary-age-related-tauopathy)
• [Frontotemporal Dementia (FTD)](/diseases/frontotemporal-dementia)

Pathobiology and Mechanisms

• [Tauopathy](/mechanisms/tauopathy)
• [4R Tauopathy Mechanism](/mechanisms/4r-tauopathy)
• [Tau Protein Aggregation](/mechanisms/tau-protein-aggregation)
• [Neuroinflammation in Tauopathy](/mechanisms/neuroinflammation-tauopathy)
• [Autophagy-Lysosomal Dysfunction in Tauopathy](/mechanisms/autophagy-lysosomal-dysfunction-tauopathy)
• [Mitochondrial Dysfunction in Tauopathy](/mechanisms/mitochondrial-dysfunction-tauopathy)

Biomarkers and Phenotyping

• [Tau PET in CBS/PSP](/biomarkers/tau-pet-cbs-psp)
• [MRI Atrophy Patterns in CBS/PSP](/biomarkers/mri-atrophy-cbs-psp)
• [DTI White Matter Changes in CBS/PSP](/biomarkers/dti-white-matter-cbs-psp)
• [PSP Biomarker Framework](/biomarkers/progressive-supranuclear-psp-biomarkers)

Circuit and Cell-Type Context

• [Red Nucleus Neurons in PSP](/cell-types/red-nucleus-psp)
• [Subthalamic Nucleus Neurons in PSP](/cell-types/subthalamic-nucleus-psp)
• [Globus Pallidus Neurons in CBD](/cell-types/globus-pallidus-cbd)
• [Striatal Interneurons in CBD](/cell-types/striatal-interneurons-cbd)
• [Locus Coeruleus Neurons in PSP](/cell-types/locus-coeruleus-psp)

Therapeutic and Care Pathways

• [CBS/PSP Daily Action Plan](/therapeutics/cbs-psp-daily-action-plan)
• [CBS/PSP Rehabilitation Guide](/therapeutics/cbs-psp-rehabilitation-guide)
• [CBS/PSP Clinical Trials Guide](/therapeutics/cbs-psp-clinical-trials-guide)
• [CBS/PSP Treatment Rankings](/therapeutics/cbs-psp-treatment-rankings)
• [Lithium for Tauopathy](/therapeutics/lithium-tauopathy)
• [Rapamycin for Tauopathy](/therapeutics/rapamycin-tauopathy)
• [TUDCA/UDCA in Neurodegeneration](/therapeutics/tudca-udca-neurodegeneration)

Brain Atlas Resources

• [Allen Human Brain Atlas - PSP](https://human.brain-map.org/microarray/search/show?search_term=PSP)
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/)
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/)

References

[@milbrandt2000]: Milbrandt J, et al. [Persephin: A GDNF family member with selective tropism for motor neurons](https://doi.org/10.1016/S0896-6273(00)00056-8/). Neuron. 2000.

[@baloh1998]: Baloh RH, et al. [Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons](https://doi.org/10.1016/S0896-6273(00)80901-0/). Neuron. 1998;20(1):115-127.

[@airaksinen2002]: Airaksinen MS, Saarma M. [The GDNF family: signalling, biological functions and therapeutic value](https://doi.org/10.1038/nrn843/). Nat Rev Neurosci. 2002;3(5):383-394.

[@masure1999]: Masure S, et al. [Identification and characterization of an alternatively spliced GDNF receptor alpha-1 (GFR alpha-1) mRNA](https://doi.org/10.1016/S0169-328X(99)00022-4/). Brain Res Mol Brain Res. 1999;64(2):131-143.

Pathway Context

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Aquaporin-4 Polarization Rescue](/hypothesis/h-c8ccbee8) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: AQP4
• [Microglial Purinergic Reprogramming](/hypothesis/h-5daecb6e) — <span style="color:#81c784;font-weight:600">0.66</span> · Target: P2RY12
• [Sphingolipid Metabolism Reprogramming](/hypothesis/h-6657f7cd) — <span style="color:#81c784;font-weight:600">0.61</span> · Target: CERS2
• [Complement C1q Subtype Switching](/hypothesis/h-5a55aabc) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: C1QA
• [Glial Glycocalyx Remodeling Therapy](/hypothesis/h-c35493aa) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: HSPG2
• [Ephrin-B2/EphB4 Axis Manipulation](/hypothesis/h-e6437136) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: EPHB4
• [Netrin-1 Gradient Restoration](/hypothesis/h-05b8894a) — <span style="color:#ffd54f;font-weight:600">0.44</span> · Target: NTN1

Related Analyses:

• [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) &#x1f504;

Pathway Diagram

The following diagram shows the key molecular relationships involving PSP Gene - Persephin discovered through SciDEX knowledge graph analysis: